Skip to content

Monitoring the trend of SARS-CoV-2, Dengue and Chikungunya infection transmission in the general population, India

Establish serial sero-surveillance to monitor the trend of SARS-CoV-2, Dengue and Chikungunya infection transmission in the general population, India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030520
Enrollment
25000
Registered
2021-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Guru Rajesh Jammy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Survey will be carried out in individuals above 2 years of age and all individuals currently residing and likely to stay till the end of study (1 year) in the study area will be considered eligible for inclusion.

Exclusion criteria

Exclusion criteria: Not Applicable

Design outcomes

Primary

MeasureTime frame
I.Estimate the sero-prevalence of SARS-CoV-2 infection in the general population II. Estimate the 4 monthly incidence of SARS-CoV-2 infection based on serial sero-surveys III. Estimate cumulative sero-conversion of SARS-CoV-2 infection over one year period IV. Estimate the sero-prevalence and annual sero conversion of Dengue and Chikungunya in a sub sample of the study Timepoint: I.At the end of One year II.At four months interval for one year III. At the end of one year IV.At the end of one year

Secondary

MeasureTime frame
I.Monitor the trend of SARS-CoV-2 transmission in the general population II. Determine the prevalence and incidence of SARS CoV2 sero-positivity among the members of the households with at least one seropositive individual (clustering of infection at household level) Determine the risk factors for SARS-CoV-2 infection III. Determine the duration of persistence of antibodies in individuals tested positive for SARS-CoV-2 infection Timepoint: I.At four months interval for one year II.At four months interval for one year and at the end of one year III.At four months intervals for one year

Countries

India

Contacts

Public ContactDr Guru Rajesh Jammy

SHARE INDIA (Society for Health Allied Research and Education,INDIA)

jammyrajesh@sharefoundations.org9989924783

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026